Microencapsulated antifungal agents, dealcoholized silicone sealants and their preparation methods
By preparing microcapsule antifungal agents with deformation adaptability and thermal stability, the problem of mold growth in silicone sealants under high temperature and high humidity environments has been solved. This has enabled the controllable release of the antifungal agent in response to humidity and long-lasting antifungal effect, thereby improving the service life and environmental friendliness of silicone sealants.
Patent Information
- Application Number
- CN202611474492.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-09-21
- Publication Date
- 2026-11-17
AI Technical Summary
Traditional silicone sealants are prone to mold growth in high temperature and high humidity environments, leading to blackening, aging, and adhesion failure of the adhesive layer. Existing anti-mold agents are easily replaced and precipitated by silicone oil during high temperature dehydration processing, resulting in a decrease in anti-mold performance and an inability to achieve controlled release in response to humidity.
Microencapsulated antifungal agents are used, with the capsule walls prepared from diisocyanate, fatty diamine, and phenyl polyamino aromatic amine, forming capsule walls with good deformation adaptability and thermal stability, enabling controllable release of antifungal agents in response to humidity, and added to dealcoholized silicone sealants.
It achieves long-lasting mildew prevention in high temperature and high humidity environments, the capsule wall is resistant to mechanical stress, the mildew inhibitor can be released in a controlled manner in high humidity environments, extending service life, and is friendly to building substrates.
Smart Images

Figure SMS_1 
Figure SMS_2 
Figure SMS_3
Abstract
Description
Technical Field
[0001] This invention belongs to the field of sealant technology, specifically relating to a microcapsule antifungal agent, a de-alcoholized silicone sealant, and their preparation methods. Background Technology
[0002] Single-component, alcohol-free silicone sealants are widely used in sealing applications such as kitchens, bathrooms, and building curtain walls due to their non-toxicity and excellent weather resistance. However, traditional silicone sealants are prone to mold growth in high-temperature and high-humidity environments like bathrooms and kitchens, leading to blackening, aging, and adhesion failure of the sealant layer, severely impacting its lifespan and aesthetics. Long-lasting mold prevention has become a key technological direction in the industry. Past methods of directly adding mold inhibitors have problems such as rapid migration, uneven release, short-term failure, substrate contamination, and impact on storage stability.
[0003] To achieve long-lasting mold prevention, numerous solutions have been proposed in the industry. For example, CN121950248A proposes using a silane coupling agent to surface-modify the mold inhibitor and loading it with BIT-loaded silver-impregnated nano-silica to construct an organic / inorganic synergistic and slow-release mold-preventing network, thereby achieving slow-release and long-lasting mold prevention. However, the mold inhibitor relies solely on pore physical confinement, and during high-temperature dehydration processing, small molecules are easily replaced and precipitated by silicone oil, leading to continuous loss during long-term storage and under high humidity and heat conditions, resulting in a decline in mold-preventing performance. Additionally, CN118206951A proposes using porous silica prepared by sodium silicate acidification as a carrier, relying on pore capillary action to load antibacterial components, combined with inorganic zinc oxide and quaternized silicone oil to create a compound mold inhibitor. This type of physical adsorbent relies solely on pores to bind the antifungal agent. During high-temperature mixing in the production process, small-molecule antifungal agents are easily replaced and precipitated by the silicone oil in the system, causing colloidal yellowing and premature loss of antifungal activity. The porous silica channels are permanently open, and even in dry environments, the antibacterial components will continue to be lost, making it impossible to achieve controlled release in response to humidity. Under long-term humid and hot conditions, the antifungal effect is greatly shortened. Summary of the Invention
[0004] The purpose of this invention is to provide a microcapsule antifungal agent whose capsule wall has good deformability, thermal stability and density, and can achieve controllable release of antifungal agent in response to humidity, thus achieving the advantages of high temperature and high humidity resistance and longer-lasting antifungal effect.
[0005] The following technical solutions are used to achieve the above objectives.
[0006] In a first aspect, the present invention provides a microcapsule antifungal agent, the microcapsule antifungal agent comprising a core and a capsule wall encapsulating the core; the core comprising an antifungal agent; the capsule wall being prepared from diisocyanate, fatty diamine and phenyl polyamino aromatic amine;
[0007] The structural formula of the aliphatic diamine is as follows:
[0008]
[0009] In the formula, R1 is a divalent group with a total number of carbon atoms of 2 to 15, and the divalent group is selected from one or a combination of linear, branched or cyclic alkylene, alkenyl or aryl groups;
[0010] The phenyl-containing polyamino aromatic amine is selected from at least one of o-phenylenediamine, p-phenylenediamine, 2,4-diaminophenol, m-phenylenediamine, 1,3,5-triaminobenzene, and 1,2,4-triaminobenzene.
[0011] In some embodiments, the molar ratio of the antifungal agent, diisocyanate, fatty diamine and phenyl polyamino aromatic amine is 2~5:1:0.2~0.8:0.1~0.5, preferably 3~4:1:0.45~0.55:0.25~0.35.
[0012] In some embodiments, the antifungal agent is at least one of 1,2-benzisothiazolin-3-one, methylisothiazolinone, and thiabendazole.
[0013] In some embodiments, the diisocyanate is at least one selected from hexamethylene diisocyanate, isophorone diisocyanate, toluene diisocyanate, and diphenylmethane diisocyanate.
[0014] In some embodiments, the aliphatic diamine is isophorone diamine; the phenyl-containing polyamino aromatic amine is m-phenylenediamine.
[0015] In a second aspect, the present invention provides a method for preparing the microcapsule antifungal agent as described above, comprising the following steps:
[0016] S1. Mix and dissolve the antifungal agent with an organic solvent, add diisocyanate and stir to obtain an oil phase solution;
[0017] S2. Mix and dissolve water with a nonionic emulsifier, then add aliphatic diamine and phenyl polyamino aromatic amine, and stir to obtain an amine aqueous solution;
[0018] S3. The oil phase solution is added dropwise to the amine aqueous solution to carry out the emulsification reaction;
[0019] S4. The emulsion system that has been emulsified is subjected to a polymerization reaction.
[0020] In some embodiments, in step S3, the temperature of the emulsification reaction is 30-35°C and the reaction time is 20-40 min.
[0021] And / or, in step S4, the polymerization temperature is 45℃~60℃, and the reaction time is 2h~5h;
[0022] And / or, in step S1, the organic solvent is ethyl acetate;
[0023] And / or, in step S2, the nonionic emulsifier is Tween 80.
[0024] In a third aspect, the present invention provides a dealcoholized silicone sealant, prepared by weight from the following raw material components:
[0025] 100 parts of α,ω-dihydroxypolydimethylsiloxane
[0026] 4-8 parts of dimethyl silicone oil
[0027] 70-90 parts of heavy calcium carbonate
[0028] 80-110 parts of light calcium carbonate
[0029] Microencapsulated antifungal agent 0.5~3.5 parts
[0030] 2-6 parts of crosslinking agent
[0031] 1-2 parts of silane coupling agent
[0032] 1-2 parts catalyst;
[0033] The microcapsule antifungal agent is the microcapsule antifungal agent according to any one of claims 1-4.
[0034] In some embodiments, the viscosity of the α,ω-dihydroxypolydimethylsiloxane at 25°C is 5000 mPa·s to 150000 mPa·s;
[0035] And / or, the viscosity of the dimethyl silicone oil at 25°C is 100 mPa·s to 10000 mPa·s;
[0036] And / or, the crosslinking agent is methyltrimethoxysilane;
[0037] And / or, the silane coupling agent is at least one selected from γ-aminopropyltrimethoxysilane, γ-aminopropyltriethoxysilane, N-(β-aminoethyl)-γ-aminopropyltrimethoxysilane, N-β-(aminoethyl)-γ-aminopropylmethyldimethoxysilane, glycidyltriethoxysilane, and glycidyltrimethoxysilane;
[0038] And / or, the catalyst is diisopropyl bis(ethyl acetoacetate) titanate;
[0039] And / or, the light calcium carbonate has a particle size of 20-200 nm and is light calcium carbonate treated with fatty acids.
[0040] In some embodiments, the sample is prepared from the following raw material components in parts by weight:
[0041] 100 parts of α,ω-dihydroxypolydimethylsiloxane
[0042] 5-7 parts of dimethyl silicone oil
[0043] 78-82 parts of heavy calcium carbonate
[0044] 98-102 parts of light calcium carbonate
[0045] Microencapsulated antifungal agent 2-2.5 parts
[0046] 3-5 parts of crosslinking agent
[0047] 1.5 to 2 parts of silane coupling agent
[0048] Catalyst 1.5~2 parts.
[0049] In a fourth aspect, the present invention provides a method for preparing the alcohol-free silicone sealant as described above, comprising the following steps:
[0050] α,ω-dihydroxypolydimethylsiloxane, dimethyl silicone oil, heavy calcium carbonate and light calcium carbonate are added to a kneader, the temperature is controlled at 60℃~160℃, the vacuum degree is -0.06 MPa~-0.09 MPa, and the dehydration and mixing is carried out for 45min~130min. After cooling, the base material is obtained.
[0051] The obtained base material and microcapsule antifungal agent were added to a planetary mixer and dispersed and stirred for 5-10 minutes at a vacuum of -0.06 MPa to -0.09 MPa and a rotation speed of 600-720 rpm. Then, the crosslinking agent, coupling agent and catalyst were added to the planetary mixer and stirred continuously for 10-45 minutes at a vacuum of -0.045 MPa to -0.09 MPa and a rotation speed of 600-720 rpm to finally obtain the de-alcoholized silicone sealant.
[0052] In this invention, a microcapsule antifungal agent with a rigid-flexible composite aromatic polyurea encapsulated in a specific aliphatic diamine and a phenyl polyamino aromatic amine can be prepared. This gives the microcapsule antifungal agent excellent deformability, allowing it to withstand the mechanical stress caused by the curing deformation and thermal expansion and contraction of silicone sealant when added, effectively preventing capsule breakage and leakage. It also significantly improves the thermal stability and structural density of the capsule wall, exhibits excellent high-temperature slow-release performance, greatly extends its service life, and possesses humidity-responsive characteristics, allowing for controlled release of the antifungal agent only under high humidity conditions, thus significantly extending the antifungal period. It is environmentally friendly, releasing small alcohol molecules during curing, has a low odor, and does not corrode building substrates such as metals, concrete, and glass. Detailed Implementation
[0053] To facilitate understanding of the present invention, a more complete description will be provided below. The present invention can be implemented in many different forms and is not limited to the embodiments described herein. Rather, these embodiments are provided to provide a thorough and complete understanding of the disclosure of the present invention.
[0054] Unless otherwise specified, experimental methods in the following examples are generally performed under standard conditions or as recommended by the manufacturer. All commonly used chemical reagents used in the examples are commercially available products.
[0055] Unless otherwise defined, all technical and scientific terms used in this invention have the same meaning as commonly understood by one of ordinary skill in the art to which this invention pertains. The terminology used in this specification is for the purpose of describing particular embodiments only and is not intended to limit the invention. The term "and / or" as used in this invention includes any and all combinations of one or more of the associated listed items.
[0056] The following describes the specific solution in conjunction with embodiments of the present invention.
[0057] Example 1:
[0058] (1) The preparation method of the microcapsule antifungal agent includes the following steps:
[0059] Weigh the raw materials according to the following weight proportions:
[0060] 100 parts deionized water, 1.5 parts Tween 80, 5.6 parts isophorone diamine, 2.4 parts m-phenylenediamine, 38 parts 1,2-benzisothiazolin-3-one, 14 parts ethyl acetate, and 16 parts isophorone diisocyanate.
[0061] Preparation steps:
[0062] Under normal temperature stirring conditions, the antifungal agent 1,2-benzisothiazolin-3-one was thoroughly mixed and dissolved with the organic solvent ethyl acetate, and then isophorone diisocyanate was added and stirred for 20 minutes to form a homogeneous and transparent oil phase solution.
[0063] Add nonionic emulsifier Tween 80 to deionized water and stir until completely dissolved; then simultaneously add isophorone diamine and m-phenylenediamine and stir at low speed at room temperature for 30 minutes to obtain a homogeneous amine aqueous solution.
[0064] The prepared oil phase solution was slowly and uniformly added dropwise to the amine aqueous solution, with mechanical stirring throughout the process at a speed of 2500 r / min and an emulsification time of 40 minutes to form a stable microemulsion. The temperature during the emulsification process was controlled at 35℃.
[0065] After emulsification, the emulsion system is gradually heated to 60°C and stirred at a low speed for 4 hours.
[0066] After polymerization, the mixture was stirred and matured at a constant temperature of 60℃ for 2 hours.
[0067] After aging, the emulsion was cooled to room temperature and centrifuged at 8000 r / min for 10 minutes. The lower layer of solid microcapsule precipitate was collected and washed multiple times with anhydrous ethanol. Subsequently, it was dried under low temperature vacuum at 50℃ for 12 hours and ground through a 300-mesh sieve to obtain a white microcapsule antifungal agent powder.
[0068] (2) The preparation method of dealcohol-type silicone sealant includes the following steps:
[0069] 100 parts of α,ω-dihydroxypolydimethylsiloxane with a viscosity of 50000 mPa·s, 6 parts of dimethyl silicone oil with a viscosity of 500 mPa·s, 80 parts of heavy calcium carbonate, and 100 parts of light calcium carbonate (Guangxi Huana New Material Co., Ltd., item number CCS-23i) were added to a kneader and dehydrated and blended at 120℃ and a vacuum of -0.09 MPa for 120 min. The resulting base material was then cooled and set aside for later use.
[0070] The prepared base material and 0.5 parts of microcapsule antifungal agent were added to a planetary mixer and stirred. Then, 4 parts of methyltrimethoxysilane, 1.5 parts of γ-aminopropyltrimethoxysilane, and 1.5 parts of diisopropyl bis(ethyl acetoacetate) titanate catalyst were added. The chemical reaction was carried out for 45 minutes under a vacuum of -0.09 MPa and a rotation speed of 600 rpm to finally obtain the de-alcoholized silicone sealant.
[0071] Example 2
[0072] (1) The raw material components, dosage and preparation method of the microcapsule antifungal agent are the same as in Example 1.
[0073] (2) The preparation method of dealcohol-type silicone sealant includes the following steps:
[0074] 100 parts of α,ω-dihydroxypolydimethylsiloxane with a viscosity of 50000 mPa·s, 6 parts of dimethyl silicone oil with a viscosity of 500 mPa·s, 80 parts of heavy calcium carbonate, and 100 parts of light calcium carbonate (Guangxi Huana New Material Co., Ltd., item number CCS-23i) were added to a kneader and dehydrated and blended at 120℃ and a vacuum of -0.09 MPa for 120 min. The resulting base material was then cooled and set aside for later use.
[0075] The base material and 2 parts of the microcapsule antifungal agent prepared above were added to a planetary mixer and stirred. Then, 4 parts of methyltrimethoxysilane, 1.5 parts of γ-aminopropyltrimethoxysilane, and 1.5 parts of diisopropyl bis(ethyl acetoacetate) titanate catalyst were added. The chemical reaction was carried out for 45 minutes under a vacuum of -0.09 MPa and a rotation speed of 600 rpm to finally obtain the de-alcoholized silicone sealant.
[0076] Example 3
[0077] (1) The raw material components, dosage and preparation method of the microcapsule antifungal agent are the same as in Example 1.
[0078] (2) The preparation method of dealcohol-type silicone sealant includes the following steps:
[0079] 100 parts of α,ω-dihydroxypolydimethylsiloxane with a viscosity of 50000 mPa·s, 6 parts of dimethyl silicone oil with a viscosity of 500 mPa·s, 80 parts of heavy calcium carbonate, and 100 parts of light calcium carbonate (Guangxi Huana New Material Co., Ltd., item number CCS-23i) were added to a kneader and dehydrated and blended at 120℃ and a vacuum of -0.09 MPa for 120 min. The resulting base material was then cooled and set aside for later use.
[0080] The base material and 3.5 parts of the microcapsule antifungal agent prepared above were added to a planetary mixer and stirred. Then, 4 parts of methyltrimethoxysilane, 1.5 parts of γ-aminopropyltrimethoxysilane, and 1.5 parts of diisopropyl bis(ethyl acetoacetate) titanate catalyst were added. The chemical reaction was carried out for 45 minutes under a vacuum of -0.09 MPa and a rotation speed of 600 rpm to finally obtain the de-alcoholized silicone sealant.
[0081] Example 4
[0082] (1) The preparation method of the microcapsule antifungal agent includes the following steps:
[0083] Weigh the raw materials according to the following weight proportions:
[0084] 100 parts deionized water, 2.2 parts Tween 80, 7.2 parts isophorone diamine, 3.6 parts m-phenylenediamine, 45 parts 1,2-benzisothiazolin-3-one, 14 parts ethyl acetate, and 16 parts isophorone diisocyanate.
[0085] The preparation steps of this microcapsule antifungal agent are the same as in Example 1.
[0086] (2) The raw material composition, dosage and preparation method of the de-alcoholized silicone sealant are the same as in Example 2.
[0087] Example 5
[0088] (1) The preparation method of the microcapsule antifungal agent includes the following steps:
[0089] Weigh the raw materials according to the following weight proportions:
[0090] 100 parts deionized water, 1.5 parts Tween 80, 4.5 parts isophorone diamine, 1.8 parts m-phenylenediamine, 30 parts 1,2-benzisothiazolin-3-one, 14 parts ethyl acetate, and 16 parts isophorone diisocyanate.
[0091] The preparation steps of this microcapsule antifungal agent are the same as in Example 1.
[0092] (2) The raw material composition, dosage and preparation method of the de-alcoholized silicone sealant are the same as in Example 2.
[0093] Comparative Example 1
[0094] The difference between this comparative example and Example 2 is that no antifungal agents or microencapsulated antifungal agents are added in the preparation of the dealcoholized silicone sealant. The amounts of other raw materials and the preparation process are completely consistent with Example 2.
[0095] The preparation method of this dealcoholized silicone sealant includes the following steps:
[0096] 100 parts of α,ω-dihydroxypolydimethylsiloxane with a viscosity of 50000 mPa·s, 6 parts of dimethyl silicone oil with a viscosity of 500 mPa·s, 80 parts of heavy calcium carbonate, and 100 parts of light calcium carbonate were added to a kneader and dehydrated and blended at 120℃ and a vacuum of -0.09 MPa for 120 min. The resulting base material was then cooled and set aside for later use.
[0097] The base material prepared above was added to a planetary mixer and stirred. Then, 4 parts of methyltrimethoxysilane, 1.5 parts of γ-aminopropyltrimethoxysilane, and 1.5 parts of diisopropyl bis(ethyl acetoacetate) titanate catalyst were added. The chemical reaction was carried out for 45 minutes under a vacuum of -0.09 MPa and a rotation speed of 600 rpm to finally obtain a dealcoholized silicone sealant.
[0098] Comparative Example 2
[0099] The difference between this comparative example and Example 2 is that in the preparation of the dealcoholized silicone sealant, only an equal amount of antifungal agent is added, without the addition of microencapsulated antifungal agent. The amounts of other raw materials and the preparation process are completely consistent with Example 2.
[0100] The preparation method of this dealcoholized silicone sealant includes the following steps:
[0101] 100 parts of α,ω-dihydroxypolydimethylsiloxane with a viscosity of 50000 mPa·s, 6 parts of dimethyl silicone oil with a viscosity of 500 mPa·s, 80 parts of heavy calcium carbonate, and 100 parts of light calcium carbonate were added to a kneader and dehydrated and blended at 120℃ and a vacuum of -0.09 MPa for 120 min. The resulting base material was then cooled and set aside for later use.
[0102] The base material and 2 parts of the mildew inhibitor 1,2-benzisothiazolin-3-one prepared above were added to a planetary mixer and stirred. Then, 4 parts of methyltrimethoxysilane, 1.5 parts of γ-aminopropyltrimethoxysilane, and 1.5 parts of diisopropyl bis(ethyl acetoacetate) titanate catalyst were added. The chemical reaction was carried out for 45 minutes under a vacuum of -0.09 MPa and a rotation speed of 600 rpm to finally obtain the de-alcoholized silicone sealant.
[0103] Comparative Example 3
[0104] The difference between this comparative example and Example 2 is that no phenyl polyamino aromatic amine is added in the preparation of the microcapsule antifungal agent. The weight parts of its raw material components are as follows:
[0105] 100 parts deionized water, 1.5 parts Tween 80, 8 parts isophorone diamine, 38 parts 1,2-benzisothiazolin-3-one, 14 parts ethyl acetate, and 16 parts isophorone diisocyanate.
[0106] The amount of other raw materials and the preparation process are completely consistent with those in Example 2.
[0107] Comparative Example 4
[0108] The difference between this comparative example and Example 2 is that no fatty diamine is added in the preparation of the microcapsule antifungal agent. The weight parts of its raw material components are as follows:
[0109] 100 parts deionized water, 1.5 parts Tween 80, 8 parts m-phenylenediamine, 38 parts 1,2-benzisothiazolin-3-one, 14 parts ethyl acetate, and 16 parts isophorone diisocyanate.
[0110] The amount of other raw materials and the preparation process are completely consistent with those in Example 2.
[0111] Comparative Example 5
[0112] The difference between this comparative example and Example 2 is that in the preparation of the microcapsule antifungal agent, the fatty diamine and the phenyl polyamino aromatic amine are replaced with diols. The weight parts of the raw material components are as follows:
[0113] 100 parts deionized water, 1.5 parts Tween 80, 8 parts 1,4-butanediol, 38 parts 1,2-benzisothiazolin-3-one, 14 parts ethyl acetate, and 16 parts isophorone diisocyanate.
[0114] The amount of other raw materials and the preparation process are completely consistent with those in Example 2.
[0115] Comparative Example 6
[0116] The difference between this comparative example and Example 2 is that in the preparation of the microcapsule antifungal agent, the phenyl polyamino aromatic amine is replaced with a diol. The weight parts of its raw material components are as follows:
[0117] 100 parts deionized water, 1.5 parts Tween 80, 5.6 parts isophorone diamine, 2.4 parts 1,4-butanediol, 38 parts 1,2-benzisothiazolin-3-one, 14 parts ethyl acetate, and 16 parts isophorone diisocyanate.
[0118] The amount of other raw materials and the preparation process are completely consistent with those in Example 2.
[0119] Comparative Example 7
[0120] The difference between this comparative example and Example 2 is that in the preparation of the microcapsule antifungal agent, the fatty diamine is replaced with a diol. The weight parts of its raw material components are as follows:
[0121] 100 parts deionized water, 1.5 parts Tween 80, 2.4 parts m-phenylenediamine, 5.6 parts 1,4-butanediol, 38 parts 1,2-benzisothiazolin-3-one, 14 parts ethyl acetate, and 16 parts isophorone diisocyanate.
[0122] The amount of other raw materials and the preparation process are completely consistent with those in Example 2.
[0123] Performance testing
[0124] The de-alcoholized silicone sealant in the examples and comparative examples was pneumatically extruded for 30 seconds at (23±2)℃ according to GB / T 13477.4-2017 Test Methods for Building Sealing Materials Part 4: Determination of Extrudability of Original Packaging Single Component Sealing Materials, to obtain the extrusion rate data.
[0125] According to GB / T 13477.5-2017 Test methods for building sealing materials - Part 5: Determination of surface drying time, the surface drying time data were obtained.
[0126] H-type specimens were prepared according to GB / T 13477.8-2017 Test Methods for Building Sealing Materials Part 8: Determination of Tensile Adhesion, and cured for 28 days under standard conditions of (23±2)℃ and (50±10)% relative humidity. Subsequently, the specimens were stretched to failure on a tensile testing machine at (23±2)℃ and a speed of (5.5±0.7) mm / min, and the tensile strength, maximum tensile strength, and maximum elongation were recorded.
[0127] The initial mildew resistance level of the silicone sealant was tested according to GB / T1741—2020. To accelerate the simulation of the mildew resistance performance of the above-mentioned de-alcoholized silicone sealant after long-term use, this invention will examine the mildew resistance level of the de-alcoholized silicone sealant after immersion in hot water for different times and after heat aging. Specifically, the de-alcoholized silicone sealant prepared in the above examples and comparative examples was prepared into samples with a length, width and height of 50mm*50mm*2mm. After curing at 23±2℃ and 50±10%RH for 28 days, the samples were immersed in water at 55±2℃ for 400h, 800h and 1200h, and then placed under standard conditions for 48h. The mildew resistance level of the samples was then tested according to GB / T1741—2020.
[0128] The specific operation of heat aging is to prepare samples with length, width and height of 50mm*50mm*2mm for the de-alcoholized silicone sealant obtained in the above embodiments and comparative examples. After curing at 23±2℃ and 50±10%RH for 28 days, the samples are placed in a 70℃ oven for 14 days for aging. The anti-mildew level of the samples is then tested according to GB / T1741—2020.
[0129] The test results of the de-alcoholized silicone sealants prepared in Examples 1-5 are shown in Table 1 below, and the test results of the de-alcoholized silicone sealants prepared in Examples 2 and Comparative Examples 1-7 are shown in Table 2 below.
[0130] Table 1 Performance data for Examples 1-5:
[0131]
[0132] Table 2 Performance data for Example 2 and Comparative Examples 1-7:
[0133]
[0134]
[0135] The results from Examples 1-5 show that when the amount of microcapsule antifungal agent added is between 0.5 and 3.5 parts, the prepared de-alcoholized silicone sealant has the advantages of low cost, good workability, excellent mechanical properties, and good antifungal performance. Example 2 has the best overall effect. In Example 1, the amount of microcapsule antifungal agent added is less than 2 parts, and its antifungal effect is not as good as that of Example 2. In Example 3, when the amount of microcapsule antifungal agent added is increased to 3.5 parts, although its antifungal effect is excellent, the cost is high, and it will increase its surface drying time and reduce the extrusion rate, thus affecting the workability. In Example 4, the amount of isophorone diamine and m-phenylenediamine was increased during the preparation of the microcapsule antifungal agent, resulting in a thicker capsule wall and a more slow-release antifungal agent. However, because the excess amine will be free outside the microcapsule antifungal agent, the polarity will increase, resulting in a decrease in the extrusion rate of the sealant, affecting its workability and increasing the cost. In Example 5, the amount of isophorone diamine and m-phenylenediamine was reduced during the preparation of the microcapsule antifungal agent. Although the cost was reduced, the antifungal effect was slightly weakened because the capsule wall was relatively thinner and the sustained-release effect of the antifungal agent was weakened.
[0136] The results of Example 2 and Comparative Examples 1-2 show that the silicone sealant with added microencapsulated antifungal agent exhibits significantly better antifungal performance after immersion than silicone sealant without added or with only added free antifungal agent. The results of Example 2 and Comparative Examples 3-4 show that the microencapsulated antifungal agent, a combination of aliphatic diamine and phenyl polyamino aromatic amine, outperforms single-component microencapsulated antifungal agents, exhibiting greater resistance to high temperature and humidity environments and longer-lasting antifungal effects. The results of Comparative Example 5 and Examples 2 and 3-4 show that while the microencapsulated antifungal agent using diols for its capsule wall provides better application performance, its antifungal and aging resistance are relatively poor. The results of Comparative Examples 5 and 6-7 show that the capsule wall synthesis includes amine compounds, which more effectively enhances the sustained-release antifungal effect than single diols. Furthermore, the microencapsulated antifungal agent, a combination of aliphatic diamine and phenyl polyamino aromatic amine, demonstrates superior antifungal performance compared to microencapsulated antifungal agents using diols.
[0137] The technical features of the above embodiments can be combined in any way. For the sake of brevity, not all possible combinations of the technical features in the above embodiments are described. However, as long as there is no contradiction in the combination of these technical features, they should be considered to be within the scope of this specification.
[0138] The embodiments described above are merely illustrative of several implementations of the present invention, and while the descriptions are relatively specific and detailed, they should not be construed as limiting the scope of the invention patent. It should be noted that those skilled in the art can make various modifications and improvements without departing from the concept of the present invention, and these all fall within the protection scope of the present invention. Therefore, the protection scope of this invention patent should be determined by the appended claims.
Claims
1. A microencapsulated antifungal agent, characterized in that, The microcapsule antifungal agent comprises a capsule core and a capsule wall encapsulating the capsule core; the capsule core comprises an antifungal agent; the capsule wall is prepared from diisocyanate, fatty diamine and phenyl polyamino aromatic amine; The structural formula of the aliphatic diamine is as follows: In the formula, R1 is a divalent group with a total number of carbon atoms of 2 to 15, and the divalent group is selected from one or a combination of linear, branched or cyclic alkylene, alkenyl or aryl groups; The phenyl-containing polyamino aromatic amine is selected from at least one of o-phenylenediamine, p-phenylenediamine, 2,4-diaminophenol, m-phenylenediamine, 1,3,5-triaminobenzene, and 1,2,4-triaminobenzene.
2. The microencapsulated antifungal agent as described in claim 1, characterized in that, The molar ratio of the antifungal agent, diisocyanate, fatty diamine and phenyl polyamino aromatic amine is 2~5:1:0.2~0.8:0.1~0.5, preferably 3~4:1:0.45~0.55:0.25~0.
35.
3. The microencapsulated antifungal agent as described in claim 1, characterized in that, The antifungal agent is at least one of 1,2-benzisothiazolin-3-one, methylisothiazolinone, and thiabendazole, preferably 1,2-benzisothiazolin-3-one; And / or, the diisocyanate is at least one of hexamethylene diisocyanate, isophorone diisocyanate, toluene diisocyanate and diphenylmethane diisocyanate, preferably isophorone diisocyanate.
4. The microencapsulated antifungal agent according to any one of claims 1-3, characterized in that, The fatty diamine is isophorone diamine; the phenyl-containing polyamino aromatic amine is m-phenylenediamine.
5. A method for preparing the microcapsule antifungal agent according to any one of claims 1-4, characterized in that, Includes the following steps: S1. Mix and dissolve the antifungal agent with an organic solvent, add diisocyanate and stir to obtain an oil phase solution; S2. Mix and dissolve water with a nonionic emulsifier, then add aliphatic diamine and phenyl polyamino aromatic amine, and stir to obtain an amine aqueous solution; S3. The oil phase solution is added dropwise to the amine aqueous solution to carry out the emulsification reaction; S4. The emulsion system that has been emulsified is subjected to a polymerization reaction.
6. The method for preparing the microcapsule antifungal agent as described in claim 5, characterized in that, In step S3, the emulsification reaction temperature is 30-35℃ and the reaction time is 20-40 min; And / or, in step S4, the polymerization temperature is 45℃~60℃, and the reaction time is 2h~5h; And / or, in step S1, the organic solvent is ethyl acetate; And / or, in step S2, the nonionic emulsifier is Tween 80.
7. A de-alcoholized silicone sealant, characterized in that, It is prepared from the following raw material components in parts by weight: 100 parts of α,ω-dihydroxypolydimethylsiloxane 4-8 parts of dimethyl silicone oil 70-90 parts of heavy calcium carbonate 80-110 parts of light calcium carbonate Microencapsulated antifungal agent 0.5~3.5 parts 2-6 parts of crosslinking agent 1-2 parts of silane coupling agent 1-2 parts catalyst; The microcapsule antifungal agent is the microcapsule antifungal agent according to any one of claims 1-4.
8. The de-alcoholized silicone sealant as described in claim 7, characterized in that, The viscosity of the α,ω-dihydroxypolydimethylsiloxane at 25°C is 5000 mPa·s to 150000 mPa·s; And / or, the viscosity of the dimethyl silicone oil at 25°C is 100 mPa·s to 10000 mPa·s; And / or, the crosslinking agent is methyltrimethoxysilane; And / or, the silane coupling agent is at least one selected from γ-aminopropyltrimethoxysilane, γ-aminopropyltriethoxysilane, N-(β-aminoethyl)-γ-aminopropyltrimethoxysilane, N-β-(aminoethyl)-γ-aminopropylmethyldimethoxysilane, glycidyltriethoxysilane, and glycidyltrimethoxysilane; And / or, the catalyst is diisopropyl bis(ethyl acetoacetate) titanate.
9. The de-alcoholized silicone sealant as described in claim 7, characterized in that, It is prepared from the following raw material components in parts by weight: 100 parts of α,ω-dihydroxypolydimethylsiloxane 5-7 parts of dimethyl silicone oil 78-82 parts of heavy calcium carbonate 98-102 parts of light calcium carbonate Microencapsulated antifungal agent 2-2.5 parts 3-5 parts of crosslinking agent 1.5 to 2 parts of silane coupling agent Catalyst 1.5~2 parts.
10. A method for preparing a dealcoholized silicone sealant according to any one of claims 7-9, characterized in that, Includes the following steps: α,ω-dihydroxypolydimethylsiloxane, dimethyl silicone oil, heavy calcium carbonate and light calcium carbonate are added to a kneader, the temperature is controlled at 60℃~160℃, the vacuum degree is -0.06 MPa~-0.09 MPa, and the dehydration and mixing is carried out for 45min~130min. After cooling, the base material is obtained. The obtained base material and microcapsule antifungal agent were added to a planetary mixer and dispersed and stirred for 5-10 minutes at a vacuum of -0.06 MPa to -0.09 MPa and a rotation speed of 600-720 rpm. Then, the crosslinking agent, coupling agent and catalyst were added to the planetary mixer and stirred continuously for 10-45 minutes at a vacuum of -0.045 MPa to -0.09 MPa and a rotation speed of 600-720 rpm to finally obtain the de-alcoholized silicone sealant.
Citation Information
Patent Citations
Long-acting mildew-proof silicone sealant and preparation method thereof
CN118206951A
Mildew-proof flame-retardant silicone sealant for buildings and preparation method thereof
CN121950248A
